Evidence map›Paper›PMID 41454654›Full record

ArticlePediatrics international : official journal of the Japan Pediatric Society

Spatial and temporal variability of respiratory syncytial virus disease seasonality in Japan, 2012-2024.

Takeshi Arashiro, Ichiro Morioka, Naruhiko Ishiwada, Oliver Martyn, Rolf Kramer, Jing Jin, Amanda Pinho, Ewen Corbelon, Satoshi Kusuda

Abstract read
In one paragraph

Article in Pediatrics international : official journal of the Japan Pediatric Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Spatial and temporal variability of respiratory syncytial virus disease seasonality in Japan, 2012-2024.Pediatrics international : official journal of the Japan Pediatric Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Takeshi ArashiroSanofi Vaccines Medical, Tokyo, Japan.ORCID https://orcid.org/0000-0002-5215-1500
Ichiro MoriokaDepartment of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan.
Naruhiko IshiwadaDepartment of Infectious Diseases, Medical Mycology Research Center, Chiba University, Chiba, Japan.
Oliver MartynSanofi Vaccines Medical, Lyon, France.ORCID https://orcid.org/0000-0001-8126-5868
Rolf KramerSanofi Vaccines Medical, Lyon, France.
Jing JinSanofi Vaccines Medical, Beijing, China.
Amanda PinhoSanofi Vaccines Medical, Lyon, France.
Ewen CorbelonHEOR, Real World Evidence, IQVIA Solutions G.K, Tokyo, Japan.
Satoshi KusudaNeonatal Research Network of Japan, Kyorin University, Tokyo, Japan.ORCID https://orcid.org/0000-0001-5318-8877

Funding

AstraZenecaSanofi
6 · The paper itself

Abstract

backgroundUnderstanding infectious disease seasonality is crucial to inform immunization timing and risk communications. This study aimed to describe trends in respiratory syncytial virus (RSV) seasonality in Japan by determining thresholds across 47 prefectures using public health surveillance data.

methodsWeekly RSV cases per sentinel (CPS) is the main indicator used in Japan. Data from approximately 3000 pediatric sentinel sites were extracted for 2012-2024. Seasonal, advisory, and alert thresholds were established via two globally utilized methods (moving epidemic methods [MEM] and fixed threshold method). Based on the established seasonal threshold, onset/duration was examined for each season during the study period.

resultsThe fixed threshold method was finally chosen to establish the seasonal threshold, while medium and high-intensity thresholds under the MEM methods were chosen as advisory and alert thresholds. The threshold values were 0.23-0.80CPS for seasonal, 0.75-2.82CPS for advisory, and 1.11-4.20CPS for alert. The epidemic periods usually lasted less than 6 months, with distinct epidemic peaks in almost all prefectures over the 13-year observation. However, unlike other temperate countries/regions such as the United States and Europe, season onset shifted drastically from September-October in 2012/2013 to around March-April in 2024 with geographic variabilities. Calling season onset after 2 consecutive weeks above the threshold resulted in no false alarms in over half the prefectures.

conclusionsIn countries such as Japan and the tropics/subtropics where the RSV seasons are less predictable, a flexible prevention strategy, tailored for each region/prefecture, using thresholds as guides, would ensure optimal protection against RSV and maximize public health benefits regardless of seasonal variability.

Indexed as

Respiratory Syncytial Virus InfectionsSeasonsChildChild, PreschoolHumansInfantJapanRespiratory Syncytial Virus, HumanepidemiologyJapanrespiratory syncytial virusseasonalitysentinel surveillance

Identifiers

PMID41454654
PMCPMC12743260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.